Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Destabilization of Microtubules01:45

Destabilization of Microtubules

2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
  1. ホーム
  2. ルテノセニルおよび1- アダマンチルパクリタキセル類はβiii- とβiva- トブリン間のバランスを乱し,大腸がんの成長と侵入性を阻害する
  1. ホーム
  2. ルテノセニルおよび1- アダマンチルパクリタキセル類はβiii- とβiva- トブリン間のバランスを乱し,大腸がんの成長と侵入性を阻害する

関連する実験動画

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.7K

ルテノセニルおよび1- アダマンチルパクリタキセル類はβIII- とβIVa- トブリン間のバランスを乱し,大腸がんの成長と侵入性を阻害する

Wojciech M Ciszewski1, Karolina Kowalczyk2, Andrzej Błauż3

  • 1Department of Molecular Cell Mechanisms, Medical University of Lodz, Mazowiecka 6/8, Lodz 92-215, Poland.

Journal of medicinal chemistry
|September 4, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

新しいパクリタキセル類はβIII- チューブリンを標的として結腸がんの化学抵抗を克服します. これらの化合物は癌細胞の成長と転移を抑制し,潜在的な二重作用療法を提供します.

さらに関連する動画

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.5K

関連する実験動画

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.7K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.5K

科学分野:

  • 薬剤化学
  • 癌 生物学
  • 分子薬理学

背景:

  • タクサンは微小管を安定させる抗がん剤です
  • 大腸がんは,しばしばβIII-チューブリン (TUBB3) のアップレギュレーションに関連して,化学抵抗を示します.
  • 抵抗を克服し,有効性を改善するために新しいタクサン類が必要です.

研究 の 目的:

  • パクリタキセルの新しいフェロセニル,ルテノセニル,および1- アダマンチル類の合成と評価.
  • 細胞毒性と侵入性に焦点を当てて,これらの類似体の結腸がん細胞に対する有効性を評価する.
  • アナログがチューブリン発現と細胞結合に及ぼす影響の基礎となる分子機構を調査する.

主な方法:

  • フェロセニル,ルテノセニル,および1- アダマンチルパクリタキセル類の合成.
  • In vitro 細胞毒性測定 (IC50の決定)
  • 細胞侵入検査
  • チューブリンイソフォーム表現の分析 (TUBB3,TUBB4a)
  • 焦点粘着複合体とインテグリンβ1信号の調査

主要な成果:

  • 合成されたアナログはパクリタキセルより有意に高い細胞毒性を示した (ナノモラーIC50値).
  • ルテノセニルと1- アダマンチル類は,大腸がん細胞の成長と侵入性を強力に抑制しました.
  • βIII-チューブリンを低下させ,βIVa-チューブリンを上昇させることが観察された.
  • 焦点結合複合体とインテグリン結合キナーゼ-インテグリン-β1軸の調節は,侵襲性の低下と関連していた.
  • 結論:

    • 新しいパクリタキセル類は,大腸がんに対する強力な抗がん作用を示しています.
    • これらのアナログはβIII-チューブリン媒介の化学抵抗を克服する.
    • これらの化合物は,腫瘍の成長を阻害し,転移を防ぐための二重作用の可能性を持っています.